Procter & Gamble is acquiring supplement brand Thorne for $3.8 billion to expand its health and wellness division and capture younger demographic sales.
Procter & Gamble shares rose 3% on Friday after the consumer products giant reported Q3 fiscal 2026 earnings that beat top and bottom line expectations, with sales up 7% year over year to $21.2 billion versus $20.5 billion expected. Adjusted EPS of $1.59 beat the $1.56 estimate. The company maintained its full-year guidance despite increased commodity costs due to the Middle East conflict, with management noting higher energy prices could negatively impact fiscal 2027 profitability.
Procter & Gamble reported fiscal third-quarter earnings that beat analysts' expectations with EPS of $1.63 versus $1.56 expected, and revenue of $21.24 billion versus $20.5 billion expected. The company reported 2% volume growth—the first time in a year—as demand improved across most segments. Beauty products led with 5% volume growth, while baby care rose 3% and fabric care increased 2%. However, grooming and health care lagged with 2% declines each. P&G reiterated its full-year sales growth forecast of 1% to 5%.
